Revelation Biosciences (REVB) Return on Equity [ROE] (2021 - 2026)
Revelation Biosciences' Return on Equity [ROE] came in at -97.62% for Q2 2026, up 144.14 percentage points from -241.76% a year earlier but down 5.46 percentage points from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Revelation Biosciences' Return on Equity [ROE] was -133.70%, up 6.76 percentage points from FY2024.
- Return on Equity [ROE] has increased in each of the last three years, though with a five-year change of -38.01 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -140.46% in FY2024 (+84.39 pp), -224.84% in FY2023 (+2055.26 pp), -2280.11% in FY2022 (-2151.45 pp) and -128.65% in FY2021 (-32.97 pp).
- The five-year range for quarterly Return on Equity [ROE] is -5646.67% (Q3 2022) to -55.72% (Q2 2023).
- Year-over-year, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of +10.57 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2023 (a gain of 5572.05 percentage points), and the weakest in Q3 2024 (a drop of 373.57 percentage points).
- Business Quant data shows REVB's Return on Equity [ROE] at -92.16% (Q1 2026), -91.33% (Q4 2025) and -111.32% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | -97.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.62% |
| Mar 31, 2026 | -92.16% |
| Dec 31, 2025 | -91.33% |
| Sep 30, 2025 | -111.32% |
| Jun 30, 2025 | -241.76% |
| Mar 31, 2025 | -215.25% |
| Dec 31, 2024 | -216.07% |
| Sep 30, 2024 | -448.19% |
| Jun 30, 2024 | -179.55% |
| Mar 31, 2024 | -110.90% |
| Dec 31, 2023 | -111.94% |
| Sep 30, 2023 | -74.62% |
| Jun 30, 2023 | -55.72% |
| Mar 31, 2023 | -106.56% |
| Dec 31, 2022 | -662.44% |
| Sep 30, 2022 | -5,646.67% |
| Dec 31, 2021 | -332.47% |
API Access
Revelation Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();